State Of Wyoming Legend Biotech Corp Transaction History

State Of Wyoming

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$33.54 - $55.0 $335 - $550	10 Added 6.21%	171 $9,000
Q1 2022 May 13, 2022	BUY	$31.02 - $48.18 $1,054 - $1,638	34 Added 26.77%	161 $6,000
Q4 2021 Feb 11, 2022	BUY	$41.14 - $56.98 $1,316 - $1,823	32 Added 33.68%	127 $6,000
Q3 2021 Feb 11, 2022	BUY	$35.31 - $50.56 $3,001 - $4,297	85 Added 850.0%	95 $5,000
Q2 2021 Feb 11, 2022	BUY	$25.8 - $41.09 $129 - $205	5 Added 100.0%	10 $0
Q1 2021 Feb 08, 2022	BUY	$23.55 - $32.4 $117 - $162	5 New	5 $0

205

74.5M

371K

387K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $6.7B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.